Search
  • Within this site
AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.
Back to search results

Scalable Lipid Bilayer Microfluidics for High-Throughput Gene Editing


Technology Benefits

Efficient High-throughput No clogging or biofouling Long-term use


Technology Application

Gene editing (stem cells, immunotherapy, research tools) Introducing large biomolecules into cells


Detailed Technology Description

Researchers led by Paul Weiss from the Departments of Chemistry & Biochemistry and Pediatrics have created a new microfluidic device for high-throughput gene editing of cells. Typical microfluidic devices have a throughput of 20,000 cells per second, but they break after passing 1 million cells due to clogging. These researchers have found a way to line the microfluidic device with a lipid bilayer to prevent cell adhesion to the fluidic device and circumvent the issue of clogging. Furthermore, this method is compatible with many different materials from which microfluidic devices are made and allows for chemical modification of the bilayer to influence cell behavior. Compared to conventional electroporation, these microfluidic devices can introduce larger DNA fragments (e.g., bacterial DNA) into cells and use less processing steps, with higher throughput, which would save hours on certain medical procedures.


Others

Background

Gene editing has many potential applications, allowing for the modification of immune cells to target cancers and the modification of stem cells to treat various diseases. Current gene-editing techniques use viruses to modify DNA; however, a new technique known as CRISPR/Cas9 has gained popularity in genetic engineering due to its efficiency and precision. To introduce CRISPR/Cas9 into cells, electroporation is used to create tiny pores in the cells for the genetic modifiers to enter through. Unfortunately, electroporation is inefficient, expensive, and creates problems with cell toxicity. Microfluidics present a more efficient option to create these pores for entry by squeezing cells through tiny channels that temporarily introduces pores due to cell stress, but these techniques suffer from short shelf lives due to clogging and biofouling.


Additional Technologies by these Inventors


Tech ID/UC Case

29497/2018-437-0


Related Cases

2018-437-0


Country/Region

USA

For more information, please click Here
Business of IP Asia Forum
Desktop View